Apraglutide by Ironwood Pharmaceuticals for Short Bowel Syndrome: Likelihood of Approval

Apraglutide is under clinical development by Ironwood Pharmaceuticals and currently in Phase III for Short Bowel Syndrome.

Cardinal Health expands recall of Monoject syringes amid compatibility problems

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Cardinal Health is removing a

February 5, 2024

Cardiac rehabilitation after TAVR underutilized by majority of patients

The vast majority of people who have a minimally invasive heart valve replacement procedure do not participate in recommended cardiac rehabilitation, a Michigan Medicine-led study

October 9, 2023

Sterigenics moves closer to end of ethylene oxide lawsuit as most claimants accept $408M deal

Dive Brief: Almost all the claimants in a lawsuit against Sterigenics over damage allegedly caused by ethylene oxide (EtO) — used to sterilize reusable medical devices — have

June 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.